Anixa Biosciences is trading up 5.4% at $2.93 as of 10:43 a.m. ET on October 23, 2026, with no clear catalyst identified. - The prior close was $2.78; no trading volume data was provided. - CEO Amit Kumar bought 8,000 shares at $2.72 each on October 22. The reported purchase may be attracting attention, but its connection to the gain is unconfirmed. - Biotech shares and major market indexes were lower, so broader trading does not explain the rise.